NDC 51662-1467

2% LIDOCAINE HCI

2% Lidocaine Hci

2% LIDOCAINE HCI is a Infiltration; Perineural Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Lidocaine Hydrochloride.

Product ID51662-1467_999b1c7b-3496-926a-e053-2a95a90ab206
NDC51662-1467
Product TypeHuman Prescription Drug
Proprietary Name2% LIDOCAINE HCI
Generic Name2% Lidocaine Hci
Dosage FormInjection, Solution
Route of AdministrationINFILTRATION; PERINEURAL
Marketing Start Date2019-12-13
Marketing CategoryANDA / ANDA
Application NumberANDA088327
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameLIDOCAINE HYDROCHLORIDE
Active Ingredient Strength20 mg/mL
Pharm ClassesAmide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51662-1467-1

20 mL in 1 VIAL, MULTI-DOSE (51662-1467-1)
Marketing Start Date2019-12-13
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
LIDOCAINE HYDROCHLORIDE20 mg/mL

Pharmacological Class

  • Amide Local Anesthetic [EPC]
  • Amides [CS]
  • Antiarrhythmic [EPC]
  • Local Anesthesia [PE]

NDC Crossover Matching brand name "2% LIDOCAINE HCI" or generic name "2% Lidocaine Hci"

NDCBrand NameGeneric Name
51662-12312% LIDOCAINE HCI2% LIDOCAINE HCI
51662-13262% LIDOCAINE HCI2% LIDOCAINE HCI
51662-14672% LIDOCAINE HCI2% LIDOCAINE HCI

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.